Necrosis: A specific form of programmed cell death?

Experimental Cell Research

Volumn 283, Issue 1, 2003, Pages 1-16

  Proskuryakov, Sergey Ya ^a   Konoplyannikov, Anatoli G ^a   Gabai, Vladimir L ^b  

^a MEDICAL RADIOLOGICAL RESEARCH CENTER   (Russian Federation)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Necrosis; Programmed cell death; Signal transduction

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 3 AMINOBENZAMIDE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADENOSINE TRIPHOSPHATE; CYCLOSPORIN A; EGTAZIC ACID; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; FAS ANTIGEN; GAMMA INTERFERON; GLUCOCORTICOID RECEPTOR; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; INSULIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN KINASE B; PROTEIN P75; PURINE P2 RECEPTOR; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNINDEXED DRUG;

APOPTOSIS; BRAIN ISCHEMIA; BRAIN PROTECTION; CANCER; CELL DEATH; CELL MEMBRANE; CELL PERMEABILIZATION; CELL POPULATION; CELL PROTECTION; CELL STRUCTURE; DRUG ACTIVITY; DRUG EFFECT; EMBRYO DEVELOPMENT; HUMAN; IMMUNE RESPONSE; INFECTION; INFLAMMATION; MACROPHAGE; MITOCHONDRION; NECROSIS; NONHUMAN; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SECOND MESSENGER;

EID: 0037330831     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(02)00027-7     Document Type: Review

References (202)

1. Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis a basic biological phenomenon with wide-ranging implications in tissue kinetics . Br. J. Cancer. 26:1972;239-257.
2. Wyllie A.H., Kerr J.F., Currie A.R. Cell death the significance of apoptosis . Int. Rev. Cytol. 68:1980;251-306.
3. Ellis H.M., Horvitz H.R. Genetic control of programmed cell death in the nematode C. elegans. Cell. 44:1986;817-829.
4. Yonehara S., Ishii A., Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169:1989;1747-1756.
5. Nagata S., Golstein P. The Fas death factor. Science. 267:1995;1449-1456.
6. Jacobson M.D., Burne J.F., Raff M.C. Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J. 13:1994;1899-1910.
7. Jacobsen M.D., Weil M., Raff M.C. Role of Ced-3/ICE-family proteases in staurosporine-induced programmed cell death. J. Cell. Biol. 133:1996;1041-1051.
8. Majno G., Joris I. Apoptosis, oncosis, and necrosis an overview of cell death . Am. J. Pathol. 146:1995;3-15.
9. Warny M., Keates A.C., Keates S., Castagliuolo I., Zacks J.K., Aboudola S., Qamar A., Pothoulakis C., LaMont J.T., Kelly C.P. p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis. J. Clin. Invest. 105:2000;1147-1156.
10. Dong Z., Saikumar P., Weinberg J.M., Venkatachalam M.A. Internucleosomal DNA cleavage triggered by plasma membrane damage during necrotic cell death involvement of serine but not cysteine proteases . Am. J. Pathol. 151:1997;1205-1213.
11. Shimizu A., Masuda Y., Kitamura H., Ishizaki M., Ohashi R., Sugisaki Y., Yamanaka N. Complement-mediated killing of mesangial cells in experimental glomerulonephritis cell death by a combination of apoptosis and necrosis . Nephron. 86:2000;152-160.
12. Blom W.M., De Bont H.J., Meijerman I., Kuppen P.J., Mulder G.J., Nagelkerke J.F. Interleukin-2-activated natural killer cells can induce both apoptosis and necrosis in rat hepatocytes. Hepatology. 29:1999;785-792.
13. Arantes R.M., Lourenssen S., Machado C.R., Blennerhassett M.G. Early damage of sympathetic neurons after co-culture with macrophages a model of neuronal injury in vitro . NeuroReport. 11:2000;177-181.
14. Ehlers S., Benini J., Kutsch S., Endres R., Rietschel E.T., Pfeffer K. Fatal granuloma necrosis without exacerbated mycobacterial growth in tumor necrosis factor receptor p55 gene-deficient mice intravenously infected with Mycobacterium avium, Infect. Immun. 67:1999;3571-3579.
15. Fratazzi C., Arbeit R.D., Carini C., Balcewicz-Sablinska M.K., Keane J., Kornfeld H., Remold H.G. Macrophage apoptosis in mycobacterial infections. J. Leukocyte Biol. 66:1999;763-764.
16. Mayhew T.M., Myklebust R., Whybrow A., Jenkins R. Epithelial integrity, cell death and cell loss in mammalian small intestine. Histol. Histopathol. 14:1999;257-267.
17. Barkla D.H., Gibson P.R. The fate of epithelial cells in the human large intestine. Pathology. 31:1999;230-238.
18. Murdoch W.J., Wilken C., Young D.A. Sequence of apoptosis and inflammatory necrosis within the formative ovulatory site of sheep follicles. J. Reprod. Fertil. 117:1999;325-329.
19. Holler N., Zaru R., Micheau O., Thome M., Attinger A., Valitutti S., Bodmer J.L., Schneider P., Seed B., Tschopp J. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat. Immunol. 1:2000;489-495.
20. Smith K.G., Strasser A., Vaux D.L. CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/APO-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease. EMBO J. 15:1996;5167-5176.
21. Chautan M., Chazal G., Cecconi F., Gruss P., Golstein P. Interdigital cell death can occur through a necrotic and caspase- independent pathway. Curr. Biol. 9:1999;967-970.
22. Saldeen J. Cytokines induce both necrosis and apoptosis via a common Bcl-2-inhibitable pathway in rat insulin-producing cells. Endocrinology. 141:2000;2003-2010.
23. Blanco F.J., Ochs R.L., Schwarz H., Lotz M. Chondrocyte apoptosis induced by nitric oxide. Am. J. Pathol. 146:1995;75-85.
24. Boone E., Vanden Berghe T., Van Loo G., De Wilde G., De Wael N., Vercammen D., Fiers W., Haegeman G., Vandenabeele P. Structure/function analysis of p55 tumor necrosis factor receptor and fas-associated death domain. Effect on necrosis in L929sA cells. J. Biol. Chem. 275:2000;37596-37603.
25. Denecker G., Vercammen D., Steemans M., Vanden Berghe T., Brouckaert G., Van Loo G., Zhivotovsky B., Fiers W., Grooten J., Declercq W., Vandenabeele P. Death receptor-induced apoptotic and necrotic cell death differential role of caspases and mitochondria . Cell Death Differ. 8:2001;829-840.
26. Vercammen D., Brouckaert G., Denecker G., Van de Craen M., Declercq W., Fiers W., Vandenabeele P. Dual signaling of the Fas receptor initiation of both apoptotic and necrotic cell death pathways . J. Exp. Med. 188:1998;919-930.
27. Schulze-Lohoff E., Hugo C., Rost S., Arnold S., Gruber A., Brune B., Sterzel R.B. Extracellular ATP causes apoptosis and necrosis of cultured mesangial cells via P2Z/P2X7 receptors. Am. J. Physiol. 275:1998;F962-F971.
28. Zaborina O., Dhiman N., Ling Chen M., Kostal J., Holder I.A., Chakrabarty A.M. Secreted products of a nonmucoid Pseudomonas aeruginosa strain induce two modes of macrophage killing external-ATP-dependent, P2Z-receptor-mediated necrosis and ATP-independent, caspase-mediated apoptosis . Microbiology. 146:2000;2521-2530.
29. Nicotera P., Lipton S.A. Excitotoxins in neuronal apoptosis and necrosis. J. Cereb. Blood Flow Metab. 19:1999;583-591.
30. Martin L.J., Sieber F.E., Traystman R.J. Apoptosis and necrosis occur in separate neuronal populations in hippocampus and cerebellum after ischemia and are associated with differential alterations in metabotropic glutamate receptor signaling pathways. J. Cereb. Blood Flow Metab. 20:2000;153-167.
31. Allen J.W., Knoblach S.M., Faden A.I. Activation of group I metabotropic glutamate receptors reduces neuronal apoptosis but increases necrotic cell death in vitro. Cell Death Differ. 7:2000;470-476.
32. Leski M.L., Valentine S.L., Coyle J.T. L-type voltage-gated calcium channels modulate kainic acid neurotoxicity in cerebellar granule cells. Brain Res. 828:1999;27-40.
33. Noh K.M., Lee J.C., Ahn Y.H., Hong S.H., Koh J.Y. Insulin-induced oxidative neuronal injury in cortical culture mediation by induced N-methyl-D-aspartate receptors . IUBMB Life. 48:1999;263-269.
34. Hong J.H., Hur K.C., Chung J.M. Potentiation of early necrotic death of glucose-starved pheochromocytoma 12 cells by nerve growth factor. Mol. Cells. 10:2000;443-451.
35. Casaccia-Bonnefil P., Kong H., Chao M.V. Neurotrophins the biological paradox of survival factors eliciting apoptosis . Cell Death Differ. 5:1998;357-364.
36. Morita K., Ishimura K., Tsuruo Y., Wong D.L. Dexamethasone enhances serum deprivation-induced necrotic death of rat C6 glioma cells through activation of glucocorticoid receptors. Brain Res. 816:1999;309-316.
37. Yoshioka A., Yamaya Y., Saiki S., Kanemoto M., Hirose G., Beesley J., Pleasure D. Non-N-methyl-D-aspartate glutamate receptors mediate oxygen glucose deprivation-induced oligodendroglial injury . Brain Res. 854:2000;207-215.
38. Perez J.F., Chemello M.E., Liprandi F., Ruiz M.C., Michelangeli F. Oncosis in MA104 cells is induced by rotavirus infection through an increase in intracellular Ca2+ concentration. Virology. 252:1998;17-27.
39. Tashiro K., Makita Y., Shike T., Shirato I., Sato T., Cynshi O., Tomino Y. Detection of cell death of cultured mouse mesangial cells induced by oxidized low-density lipoprotein. Nephron. 82:1999;51-58.
40. Meilhac O., Escargueil-Blanc I., Thiers J.C., Salvayre R., Negre-Salvayre A. Bcl-2 alters the balance between apoptosis and necrosis, but does not prevent cell death induced by oxidized low density lipoproteins. FASEB J. 13:1999;485-494.
41. Lizard G., Monier S., Cordelet C., Gesquiere L., Deckert V., Gueldry S., Lagrost L., Gambert P. Characterization and comparison of the mode of cell death, apoptosis versus necrosis, induced by 7beta-hydroxycholesterol and 7-ketocholesterol in the cells of the vascular wall. Arterioscler. Thromb. Vasc. Biol. 19:1999;1190-1200.
42. Kruman I.I., Mattson M.P. Pivotal role of mitochondrial calcium uptake in neural cell apoptosis and necrosis. J. Neurochem. 72:1999;529-540.
43. Engedal N., Saatcioglu F. Ceramide-induced cell death in the prostate cancer cell line LNCaP has both necrotic and apoptotic features. Prostate. 46:2001;289-297.
44. Mochizuki T., Asai A., Saito N., Tanaka S., Katagiri H., Asano T., Nakane M., Tamura A., Kuchino Y., Kitanaka C., Kirino T. Akt protein kinase inhibits non-apoptotic programmed cell death induced by ceramide. J. Biol. Chem. 277:2002;2790-2797.
45. Mengubas K., Fahey A.A., Lewin J., Mehta A.B., Hoffbrand A.V., Wickremasinghe R.G. Killing of T lymphocytes by synthetic ceramide is by a nonapoptotic mechanism and is abrogated following mitogenic activation. Exp. Cell Res. 249:1999;116-122.
46. Hampton M.B., Orrenius S. Dual regulation of caspase activity by hydrogen peroxide implications for apoptosis . FEBS Lett. 414:1997;552-556.
47. Palomba L., Sestili P., Columbaro M., Falcieri E., Cantoni O. Apoptosis and necrosis following exposure of U937 cells to increasing concentrations of hydrogen peroxide the effect of the poly(ADP-ribose)polymerase inhibitor 3-aminobenzamide . Biochem. Pharmacol. 58:1999;1743-1750.
48. Lee Y.J., Shacter E. Hydrogen peroxide inhibits activation, not activity, of cellular caspase-3 in vivo. Free Rad. Biol. Med. 29:2000;684-692.
49. Lee Y.J., Shacter E. Oxidative stress inhibits apoptosis in human lymphoma cells. J. Biol. Chem. 274:1999;19792-19798.
50. Troyano A., Fernandez C., Sancho P., de Blas E., Aller P. Effect of glutathione depletion on antitumor drug toxicity (apoptosis and necrosis) in U-937 human promonocytic cells the role of intracellular oxidation . J. Biol. Chem. 276:2001;47107-47115.
51. Galan A., Garcia-Bermejo M.L., Troyano A., Vilaboa N.E., de Blas E., Kazanietz M.G., Aller P. Stimulation of p38 mitogen-activated protein kinase is an early regulatory event for the cadmium-induced apoptosis in human promonocytic cells. J. Biol. Chem. 275:2000;11418-11424.
52. Gonin S., Diaz-Latoud C., Richard M.J., Ursini M.V., Imbo A., Manero F., Arrigo A.P. p53/T-antigen complex disruption in T-antigen transformed NIH3T3 fibroblasts exposed to oxidative stress correlation with the appearance of a Fas/APO-1/CD95 dependent, caspase independent, necrotic pathway . Oncogene. 18:1999;8011-8023.
53. Mannick J.B., Hausladen A., Liu L., Hess D.T., Zeng M., Miao Q.X., Kane L.S., Gow A.J., Stamler J.S. Fas-induced caspase denitrosylation. Science. 284:1999;651-654.
54. Melino G., Catani M.V., Corazzari M., Guerrieri P., Bernassola F. Nitric oxide can inhibit apoptosis or switch it into necrosis. Cell. Mol. Life Sci. 57:2000;612-622.
55. Melino G., Bernassola F., Catani M.V., Rossi A., Corazzari M., Sabatini S., Vilbois F., Green D.R. Nitric oxide inhibits apoptosis via AP-1-dependent CD95L transactivation. Cancer Res. 60:2000;2377-2383.
56. Leist M., Single B., Naumann H., Fava E., Simon B., Kuhnle S., Nicotera P. Nitric oxide inhibits execution of apoptosis at two distinct ATP- dependent steps upstream and downstream of mitochondrial cytochrome c release. Biochem. Biophys. Res. Commun. 258:1999;215-221.
57. Gow A.J., Chen Q., Gole M., Themistocleous M., Lee V.M., Ischiropoulos H. Two distinct mechanisms of nitric oxide-mediated neuronal cell death show thiol dependency. Am. J. Physiol. Cell. Physiol. 278:2000;C1099-C1107.
58. Lepri E., Gambelunghe C., Fioravanti A., Pedini M., Micheletti A., Rufini S. N-Acetylcysteine increases apoptosis induced by H(2)O(2) and mo-antiFas triggering in a 3DO hybridoma cell line. Cell. Biochem. Funct. 18:2000;201-208.
59. Crott J.W., Fenech M. Effect of vitamin C supplementation on chromosome damage, apoptosis and necrosis ex vivo. Carcinogenesis. 20:1999;1035-1041.
60. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell. 103:2000;239-252.
61. Li S., Chien S., Branemark P.I. Heat shock-induced necrosis and apoptosis in osteoblasts. J. Orthop. Res. 17:1999;891-899.
62. Gabai V.L., Meriin A.B., Yaglom J.A., Wei J.Y., Mosser D.D., Sherman M.Y. Suppression of stress kinase JNK is involved in HSP72-mediated protection of myogenic cells from transient energy deprivation HSP72 alleviates the stress-induced inhibition of JNK dephosphorylation . J. Biol. Chem. 275:2000;38088-38094.
63. Ma X.L., Kumar S., Gao F., Louden C.S., Lopez B.L., Christopher T.A., Wang C., Lee J.C., Feuerstein G.Z., Yue T.L. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation. 99:1999;1685-1691.
64. Sugino T., Nozaki K., Takagi Y., Hattori I., Hashimoto N., Moriguchi T., Nishida E. Activation of mitogen-activated protein kinases after transient forebrain ischemia in gerbil hippocampus. J. Neurosci. 20:2000;4506-4514.
65. Kim K.S., Takeda K., Sethi R., Pracyk J.B., Tanaka K., Zhou Y.F., Yu Z.X., Ferrans V.J., Bruder J.T., Kovesdi I., Irani K., Goldschmidt-Clermont P., Finkel T. Protection from reoxygenation injury by inhibition of rac1. J. Clin. Invest. 101:1998;1821-1826.
66. Matsui T., Tao J., del Monte F., Lee K.H., Li L., Picard M., Force T.L., Franke T.F., Hajjar R.J., Rosenzweig A. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation. 104:2001;330-335.
67. Punn A., Mockridge J.W., Farooqui S., Marber M.S., Heads R.J. Sustained activation of p42/p44 mitogen-activated protein kinase during recovery from simulated ischaemia mediates adaptive cytoprotection in cardiomyocytes. Biochem. J. 350:(Pt 3):2000;891-899.
68. Yue T.L., Wang C., Gu J.L., Ma X.L., Kumar S., Lee J.C., Feuerstein G.Z., Thomas H., Maleeff B., Ohlstein E.H. Inhibition of extracellular signal-regulated kinase enhances ischemia/reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. Circ. Res. 86:2000;692-699.
69. Stanciu M., Wang Y., Kentor R., Burke N., Watkins S., Kress G., Reynolds I., Klann E., Angiolieri M.R., Johnson J.W., DeFranco D.B. Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J. Biol. Chem. 275:2000;12200-12206.
70. Namura S., Iihara K., Takami S., Nagata I., Kikuchi H., Matsushita K., Moskowitz M.A., Bonventre J.V., Alessandrini A. Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia. Proc. Natl. Acad. Sci. USA. 98:2001;11569-11574.
71. Eliasson M.J., Sampei K., Mandir A.S., Hurn P.D., Traystman R.J., Bao J., Pieper A., Wang Z.Q., Dawson T.M., Snyder S.H., Dawson V.L. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat. Med. 3:1997;1089-1095.
72. Ha H.C., Snyder S.H. Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc. Natl. Acad. Sci. USA. 96:1999;13978-13982.
73. Walisser J.A., Thies R.L. Poly(ADP-ribose) polymerase inhibition in oxidant-stressed endothelial cells prevents oncosis and permits caspase activation and apoptosis. Exp. Cell Res. 251:1999;401-413.
74. Kim J.W., Won J., Sohn S., Joe C.O. DNA-binding activity of the N-terminal cleavage product of poly(ADP-ribose) polymerase is required for UV mediated apoptosis. J. Cell Sci. 113:2000;955-961.
75. Herceg Z., Wang Z.Q. Failure of poly(ADP-ribose) polymerase cleavage by caspases leads to induction of necrosis and enhanced apoptosis. Mol. Cell. Biol. 19:1999;5124-5133.
76. Shah G.M., Shah R.G., Poirier G.G. Different cleavage pattern for poly(ADP-ribose) polymerase during necrosis and apoptosis in HL-60 cells. Biochem. Biophys. Res. Commun. 229:1996;838-844.
77. Kroemer G., Reed J.C. Mitochondrial control of cell death. Nat. Med. 6:2000;513-519.
78. Genini D., Budihardjo I., Plunkett W., Wang X., Carrera C.J., Cottam H.B., Carson D.A., Leoni L.M. Nucleotide requirements for the in vitro activation of the apoptosis protein-activating factor-1-mediated caspase pathway. J. Biol. Chem. 275:2000;29-34.
79. Jiang X., Wang X. Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1. J. Biol. Chem. 275:2000;31199-31203.
80. Eguchi Y., Shimizu S., Tsujimoto Y. Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res. 57:1997;1835-1840.
81. Hartley A., Stone J.M., Heron C., Cooper J.M., Schapira A.H. Complex I inhibitors induce dose-dependent apoptosis in PC12 cells relevance to Parkinson's disease . J. Neurochem. 63:1994;1987-1990.
82. Woodgate A., MacGibbon G., Walton M., Dragunow M. The toxicity of 6-hydroxydopamine on PC12 and P19 cells. Brain Res. Mol. Brain Res. 69:1999;84-92.
83. Ohgoh M., Shimizu H., Ogura H., Nishizawa Y. Astroglial trophic support and neuronal cell death influence of cellular energy level on type of cell death induced by mitochondrial toxin in cultured rat cortical neurons . J. Neurochem. 75:2000;925-933.
84. Formigli L., Papucci L., Tani A., Schiavone N., Tempestini A., Orlandini G.E., Capaccioli S., Orlandini S.Z. Aponecrosis morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis and necrosis . J. Cell Physiol. 182:2000;41-49.
85. Kabakov A.E., Gabai V.L. Heat Shock proteins and Cytoprotection: ATP-deprived Mammalian Cells. 1997;Austin, Landes.
86. Shchepina L.A., Popova E.N., Pletjushkina O.Y., Chernyak B.V. Respiration and mitochondrial membrane potential are not required for apoptosis and anti-apoptotic action of Bcl-2 in HeLa cells. Biochemistry (Moscow). 67:2002;222-226.
87. Simm A., Bertsch G., Frank H., Zimmermann U., Hoppe J. Cell death of AKR-2B fibroblasts after serum removal a process between apoptosis and necrosis . J Cell Sci. 110:1997;819-828.
88. Schulze-Osthoff K., Krammer P.H., Droge W. Divergent signalling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO J. 13:1994;4587-4596.
89. Goossens V., De Vos K., Vercammen D., Steemans M., Vancompernolle K., Fiers W., Vandenabeele P., Grooten J. Redox regulation of TNF signaling. Biofactors. 10:1999;145-156.
90. Fiers W., Beyaert R., Declercq W., Vandenabeele P. More than one way to die apoptosis, necrosis and reactive oxygen damage . Oncogene. 18:1999;7719-7730.
91. Prins J., Ledgerwood E., Ameloot P., Vandenabeele P., Faraco P., Bright N., O'Rahilly S., Bradley J. Tumour necrosis factor induced autophagy and mitochondrial morphological abnormalities are mediated by TNFR-I and/or TNFR-II and do not invariably lead to cell death. Biochem. Soc. Trans. 26:1998;S314.
92. Li M., Beg A.A. Induction of necrotic-like cell death by tumor necrosis factor alpha and caspase inhibitors novel mechanism for killing virus-infected cells . J. Virol. 74:2000;7470-7477.
93. Lemasters J.J., Qian T., Bradham C.A., Brenner D.A., Cascio W.E., Trost L.C., Nishimura Y., Nieminen A.L., Herman B. Mitochondrial dysfunction in the pathogenesis of necrotic and apoptotic cell death. J. Bioenerg. Biomembr. 31:1999;305-319.
94. Bernardi P., Petronilli V., Di Lisa F., Forte M. A mitochondrial perspective on cell death. Trends Biochem. Sci. 26:2001;112-117.
95. Skulachev V.P. Mitochondrial physiology and pathology concepts of programmed death of organelles, cells and organisms . Mol. Aspects Med. 20:1999;139-184.
96. Skulachev V.P. Mitochondria in the programmed death phenomena - a principle of biology "it is better to die than to be wrong." IUBMB Life. 49:2000;365-373.
97. Bradham C.A., Qian T., Streetz K., Trautwein C., Brenner D.A., Lemasters J.J. The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release. Mol. Cell. Biol. 18:1998;6353-6364.
98. Tafani M., Schneider T.G., Pastorino J.G., Farber J.L. Cytochrome c-dependent activation of caspase-3 by tumor necrosis factor requires induction of the mitochondrial permeability transition. Am. J. Pathol. 156:2000;2111-2121.
99. Duchen M.R., McGuinness O., Brown L.A., Crompton M. On the involvement of a cyclosporin A sensitive mitochondrial pore in myocardial reperfusion injury. Cardiovasc. Res. 27:1993;1790-1794.
100. Griffiths E.J., Halestrap A.P. Protection by cyclosporin A of schemia/reperfusion-induced damage in isolated rat hearts. J. Mol. Cell. Cardiol. 25:1993;1461-1469.
101. Di Lisa F., Menabo R., Canton M., Barile M., Bernardi P. Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J. Biol. Chem. 276:2001;2571-2575.
102. S. Shimizu, Y. Eguchi, W. Kamiike, S. Waguri, Y. Uchiyama, H. Matsuda, Y. Tsujimoto, Retardation of chemical hypoxia-induced necrotic cell death by Bcl-2 and ICE inhibitors: possible involvement of common mediators in apoptotic and necrotic signal transduction, 12 (1996) 2045-2050.
103. Brocheriou V., Hagege A.A., Oubenaissa A., Lambert M., Mallet V.O., Duriez M., Wassef M., Kahn A., Menasche P., Gilgenkrantz H. Cardiac functional improvement by a human Bcl-2 transgene in a mouse model of ischemia/reperfusion injury. J. Gene Med. 2:2000;326-333.
104. Tan J., Town T., Placzek A., Kundtz A., Yu H., Mullan M. Bcl-X(L) inhibits apoptosis and necrosis produced by Alzheimer's beta-amyloidl-40 peptide in PC12 cells. Neurosci. Lett. 272:1999;5-8.
105. Single B., Leist M., Nicotera P. Differential effects of bcl-2 on cell death triggered under ATP-depleting conditions. Exp. Cell Res. 262:2001;8-16.
106. Schaffer S.W., Croft C.B., Solodushko V. Cardioprotective effect of chronic hyperglycemia effect on hypoxia-induced apoptosis and necrosis . Am. J. Physiol. Heart Circ. Physiol. 278:2000;H1948-H1954.
107. Shinoura N., Yoshida Y., Asai A., Kirino T., Hamada H. Relative level of expression of Bax and Bcl-XL determines the cellular fate of apoptosis/necrosis induced by the overexpression of Bax. Oncogene. 18:1999;5703-5713.
108. Virag L., Szabo C. BCL-2 protects peroxynitrite-treated thymocytes from poly(ADP-ribose) synthase (PARS)-independent apoptotic but not from PARS-mediated necrotic cell death. Free Rad. Biol. Med. 29:2000;704-713.
109. Phillips R.G., Lawrence M.S., Ho D.Y., Sapolsky R.M. Limitations in the neuroprotective potential of gene therapy with Bcl-2. Brain Res. 859:2000;202-206.
110. Vande Velde C., Cizeau J., Dubik D., Alimonti J., Brown T., Israels S., Hakem R., Greenberg A.H. BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol. Cell. Biol. 20:2000;5454-5468.
111. Jaattela M. Escaping cell death survival proteins in cancer [review] . Exp. Cell Res. 248:1999;30-43.
112. Jolly C., Morimoto R.I. Role of the heat shock response and molecular chaperones in oncogenesis and cell death. J. Natl. Cancer Inst. 92:2000;1564-1572.
113. Gabai V.L., Kabakov A.E. Rise in heat-shock protein level confers tolerance to energy deprivation. FEBS Lett. 327:1993;247-250.
114. Angelidis C.E., Lazardis I., Pagoulatos G.N. Constitutive expression of heat-shock protein 70 in mammalian cells confers thermotolerance. Eur. J. Biochem. 199:1991;35-39.
115. Simon M.M., Reikerstorfer A., Schwarz A., Krone C., Luger T.A., Jaattela M., Schwarz T. Heat shock protein 70 overexpression affects the response to ultraviolet light in murine fibroblasts evidence for increased cell viability and suppression of cytokine release . J. Clin. Invest. 95:1995;926-933.
116. Bellmann K., Jaattela M., Wissing D., Burkart V., Kolb H. Heat shock protein hsp70 overexpression confers resistance against nitric oxide. FEBS Lett. 391:1996;185-188.
117. Plumier J.C., Ross B.M., Currie R.W., Angelidis C.E., Kazlaris H., Kollias G., Pagoulatos G.N. Transgenic mice expressing the human heat shock protein 70 have improved post-ischemic myocardial recovery. J. Clin. Invest. 95:1995;1854-1860.
118. Marber M.S., Mestril R., Chi S.H., Sayen M.R., Yellon D.M., Dillmann W.H. Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury. J. Clin. Invest. 95:1995;1446-1456.
119. Hutter J.J., Mestril R., Tam E.K., Sievers R.E., Dillmann W.H., Wolfe C.L. Overexpression of heat shock protein 72 in transgenic mice decreases infarct size in vivo. Circulation. 94:1996;1408-1411.
120. Radford N.B., Fina M., Benjamin I.J., et al. Cardioprotective effects of 70-kDa heat shock protein in transgenic mice. Proc. Natl. Acad. Sci. USA. 93:1996;2339-2342.
121. Lee S.H., Kim M., Yoon B.W., Kim Y.J., Ma S.J., Roh J.K., Lee J.S., Seo J.S. Targeted hsp70.1 disruption increases infarction volume after focal cerebral ischemia in mice. Stroke. 32:2001;2905-2912.
122. Martin J.L., Mestril R., Hilal-Dandan R., Brunton L.L., Dillmann W.H. Small heat shock proteins and protection against ischemic injury in cardiac myocytes. Circulation. 96:1997;4343-4348.
123. Ray P.S., Martin J.L., Swanson E.A., Otani H., Dillmann W.H., Das D.K. Transgene overexpression of alphaB crystallin confers simultaneous protection against cardiomyocyte apoptosis and necrosis during myocardial ischemia and reperfusion. FASEB J. 15:2001;393-402.
124. Lin K.M., Lin B., Lian I.Y., Mestril R., Scheffler I.E., Dillmann W.H. Combined and individual mitochondrial HSP60 and HSP10 expression in cardiac myocytes protects mitochondrial function and prevents apoptotic cell deaths induced by simulated ischemia-reoxygenation. Circulation. 103:2001;1787-1792.
125. Burkart V., Liu H., Bellmann K., Wissing D., Jaattela M., Cavallo M.G., Pozzilli P., Briviba K., Kolb H. Natural resistance of human beta cells toward nitric oxide is mediated by heat shock protein 70. J. Biol. Chem. 275:2000;19521-19528.
126. He H., Li H.L., Lin A., Gottlieb R.A. Activation of the JNK pathway is important for cardiomyocyte death in response to simulated ischemia. Cell Death Differ. 6:1999;987-991.
127. Park K.M., Chen A., Bonventre J.V. Prevention of kidney ischemia/reperfusion-induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment. J. Biol. Chem. 276:2001;11870-11876.
128. Salvesen G.S., Dixit V.M. Caspases intracellular signalling by proteolysis . Cell. 91:1997;443-446.
129. Coelho D., Holl V., Weltin D., Lacornerie T., Magnenet P., Dufour P., Bischoff P. Caspase-3-like activity determines the type of cell death following ionizing radiation in MOLT-4 human leukaemia cells. Br. J. Cancer. 83:2000;642-649.
130. Sane A.T., Bertrand R. Caspase inhibition in camptothecin-treated U-937 cells is coupled with a shift from apoptosis to transient G1 arrest followed by necrotic cell death. Cancer Res. 59:1999;3565-3569.
131. Hirsch T., Marchetti P., Susin S.A., Dallaporta B., Zamzami N., Marzo I., Geuskens M., Kroemer G. The apoptosis-necrosis paradox apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death . Oncogene. 15:1997;1573-1581.
132. Ferrari D., Los M., Bauer M.K., Vandenabeele P., Wesselborg S., Schulze-Osthoff K. P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death. FEBS Lett. 447:1999;71-75.
133. Kolenko V., Uzzo R.G., Bukowski R., Bander N.H., Novick A.C., Hsi E.D., Finke J.H. Dead or dying necrosis versus apoptosis in caspase-deficient human renal cell carcinoma . Cancer Res. 59:1999;2838-2842.
134. Oppenheim R.W., Flavell R.A., Vinsant S., Prevette D., Kuan C.Y., Rakic P. Programmed cell death of developing mammalian neurons after genetic deletion of caspases. J. Neurosci. 21:2001;4752-4760.
135. Vercammen D., Beyaert R., Denecker G., Goossens V., Van Loo G., Declercq W., Grooten J., Fiers W., Vandenabeele P. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J. Exp. Med. 187:1998;1477-1485.
136. Glazner G.W., Chan S.L., Lu C., Mattson M.P. Caspase-mediated degradation of AMPA receptor subunits a mechanism for preventing excitotoxic necrosis and ensuring apoptosis . J. Neurosci. 20:2000;3641-3649.
137. Leist M., Single B., Castoldi A.F., Kuhnle S., Nicotera P. Intracellular adenosine triphosphate (ATP) concentration a switch in the decision between apoptosis and necrosis . J. Exp. Med. 185:1997;1481-1486.
138. Ruemmele F.M., Dionne S., Levy E., Seidman E.G. TNFalpha-induced IEC-6 cell apoptosis requires activation of ICE caspases whereas complete inhibition of the caspase cascade leads to necrotic cell death. Biochem. Biophys. Res. Commun. 260:1999;159-166.
139. Faraco P.R., Ledgerwood E.C., Vandenabeele P., Prins J.B., Bradley J.R. Tumor necrosis factor induces distinct patterns of caspase activation in WEHI-164 cells associated with apoptosis or necrosis depending on cell cycle stage. Biochem. Biophys. Res. Commun. 261:1999;385-392.
140. Warny M., Kelly C.P. Monocytic cell necrosis is mediated by potassium depletion and caspase-like proteases. Am. J. Physiol. 276:1999;C717-C724.
141. Borner C., Monney L. Apoptosis without caspases an inefficient molecular guillotine? Cell Death Differ. 6:1999;497-507.
142. Leist M., Jaattela M. Four deaths and a funeral from caspases to alternative mechanisms . Nat. Rev. Mol. Cell. Biol. 2:2001;589-598.
143. Foghsgaard L., Wissing D., Mauch D., Lademann U., Bastholm L., Boes M., Elling F., Leist M., Jaattela M. Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J. Cell Biol. 153:2001;999-1010.
144. Guicciardi M.E., Deussing J., Miyoshi H., Bronk S.F., Svingen P.A., Peters C., Kaufmann S.H., Gores G.J. Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J. Clin. Invest. 106:2000;1127-1137.
145. Kohli V., Madden J.F., Bentley R.C., Clavien P.A. Calpain mediates ischemic injury of the liver through modulation of apoptosis and necrosis. Gastroenterology. 116:1999;168-178.
146. Lankiewicz S., Marc Luetjens C., Truc Bui N., Krohn A.J., Poppe M., Cole G.M., Saido T.C., Prehn J.H. Activation of calpain I converts excitotoxic neuron death into a caspase-independent cell death. J. Biol. Chem. 275:2000;17064-17071.
147. Zhao X., Pike B.R., Newcomb J.K., Wang K.K., Posmantur R.M., Hayes R.L. Maitotoxin induces calpain but not caspase-3 activation and necrotic cell death in primary septo-hippocampal cultures. Neurochem. Res. 24:1999;371-382.
148. Guo Q., Fu W., Sopher B.L., Miller M.W., Ware C.B., Martin G.M., Mattson M.P. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knock-in mice. Nat. Med. 5:1999;101-106.
149. Basnakian A.G., Ueda N., Kaushal G.P., Mikhailova M.V., Shah S.V. DNase I-like endonuclease in rat kidney cortex that is activated during ischemia/reperfusion injury. J. Am. Soc. Nephrol. 13:2002;1000-1007.
150. Tsukada T., Watanabe M., Yamashima T. Implications of CAD and DNase II in ischemic neuronal necrosis specific for the primate hippocampus. J. Neurochem. 79:2001;1196-1206.
151. Cummings B.S., McHowat J., Schnellmann R.G. Phospholipase A(2)s in cell injury and death. J. Pharmacol. Exp. Ther. 294:2000;793-799.
152. Arai K., Ikegaya Y., Nakatani Y., Kudo I., Nishiyama N., Matsuki N. Phospholipase A2 mediates ischemic injury in the hippocampus a regional difference of neuronal vulnerability . Eur. J. Neurosci. 13:2001;2319-2323.
153. El Mahdani N.E., Ameyar M., Cai Z., Colard O., Masliah J., Chouaib S. Resistance to TNF-induced cytotoxicity correlates with an abnormal cleavage of cytosolic phospholipase A2. J. Immunol. 165:2000;6756-6761.
154. Adam-Klages S., Schwandner R., Luschen S., Ussat S., Kreder D., Kronke M. Caspase-mediated inhibition of human cytosolic phospholipase A2 during apoptosis. J. Immunol. 161:1998;5687-5694.
155. Hayflick L. Cell biology of aging. Fed. Proc. 38:1979;1847-1850.
156. Fenech M., Crott J., Turner J., Brown S. Necrosis, apoptosis, cytostasis and DNA damage in human lymphocytes measured simultaneously within the cytokinesis-block micronucleus assay description of the method and results for hydrogen peroxide . Mutagenesis. 14:1999;605-612.
157. Vit J.P., Moustacchi E., Rosselli F. ATM protein is required for radiation-induced apoptosis and acts before mitochondrial collapse. Int. J. Rad. Biol. 76:2000;841-851.
158. Fadok V.A., Bratton D.L., Henson P.M. Phagocyte receptors for apoptotic cells recognition, uptake, and consequences . J. Clin. Invest. 108:2001;957-962.
159. Henson P.M., Bratton D.L., Fadok V.A. Apoptotic cell removal. Curr. Biol. 11:2001;R795-R805.
160. Shacter E., Williams J.A., Hinson R.M., Senturker S., Lee Y.J. Oxidative stress interferes with cancer chemotherapy inhibition of lymphoma cell apoptosis and phagocytosis . Blood. 96:2000;307-313.
161. Melcher A., Gough M., Todryk S., Vile R. Apoptosis or necrosis for tumor immunotherapy what's in a name? J. Mol. Med. 77:1999;824-833.
162. Todryk S.M., Melcher A.A., Dalgleish A.G., Vile R.G. Heat shock proteins refine the danger theory. Immunology. 99:2000;334-337.
163. Srivastava P. Roles of heat-shock proteins in innate and adaptive immunity. Nat. Rev. Immunol. 2:2002;185-194.
164. Sauter B., Albert M.L., Francisco L., Larsson M., Somersan S., Bhardwaj N. Consequences of cell death exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells . J. Exp. Med. 191:2000;423-434.
165. Asea A., Kraeft S.K., Kurt-Jones E.A., Stevenson M.A., Chen L.B., Finberg R.W., Koo G.C., Calderwood S.K. HSP70 stimulates cytokine production through a CD14-dependent pathway, demonstrating its dual role as a chaperone and cytokine. Nat. Med. 6:2000;435-442.
166. Barker R.N., Erwig L., Pearce W.P., Devine A., Rees A.J. Differential effects of necrotic or apoptotic cell uptake on antigen presentation by macrophages. Pathobiology. 67:1999;302-305.
167. Todryk S., Melcher A.A., Hardwick N., Linardakis E., Bateman A., Colombo M.P., Stoppacciaro A., Vile R.G. Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake. J. Immunol. 163:1999;1398-1408.
168. Yaoita H., Ogawa K., Maehara K., Maruyama Y. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation. 97:1998;276-281.
169. Hara H., Friedlander R.M., Gagliardini V., Ayata C., Fink K., Huang Z., Shimizu-Sasamata M., Yuan J., Moskowitz M.A. Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc. Natl. Acad. Sci. USA. 94:1997;2007-2012.
170. Pomerantz B.J., Reznikov L.L., Harken A.H., Dinarello C.A. Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1 beta. Proc. Natl. Acad. Sci. USA. 98:2001;2871-2876.
171. Rabuffetti M., Sciorati C., Tarozzo G., Clementi E., Manfredi A.A., Beltramo M. Inhibition of caspase-1-like activity by Ac-Tyr-Val-Ala-Asp-chloromethyl ketone induces long-lasting neuroprotection in cerebral ischemia through apoptosis reduction and decrease of proinflammatory cytokines. J. Neurosci. 20:2000;4398-4404.
172. Kelly S., Bieneman A., Horsburgh K., Hughes D., Sofroniew M.V., McCulloch J., Uney J.B. Targeting expression of hsp70i to discrete neuronal populations using the Lmo-1 promoter assessment of the neuroprotective effects of hsp70i in vivo and in vitro . J. Cereb. Blood Flow Metab. 21:2001;972-981.
173. Liaudet L., Szabo E., Timashpolsky L., Virag L., Cziraki A., Szabo C. Suppression of poly (ADP-ribose) polymerase activation by 3-aminobenzamide in a rat model of myocardial infarction long-term morphological and functional consequences . Br. J. Pharmacol. 133:2001;1424-1430.
174. Pieper A.A., Walles T., Wei G., Clements E.E., Verma A., Snyder S.H., Zweier J.L. Myocardial postischemic injury is reduced by polyADPripose polymerase-1 gene disruption. Mol. Med. 6:2000;271-282.
175. Endres M., Wang Z.Q., Namura S., Waeber C., Moskowitz M.A. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. J. Cereb. Blood Flow Metab. 17:1997;1143-1151.
176. Tokime T., Nozaki K., Sugino T., Kikuchi H., Hashimoto N., Ueda K. Enhanced poly(ADP-ribosyl)ation after focal ischemia in rat brain. J. Cereb. Blood Flow Metab. 18:1998;991-997.
177. Moroni F., Meli E., Peruginelli F., Chiarugi A., Cozzi A., Picca R., Romagnoli P., Pellicciari R., Pellegrini-Giampietro D.E. Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia. Cell Death Differ. 8:2001;921-932.
178. Yoshimoto T., Siesjo B.K. Posttreatment with the immunosuppressant cyclosporin A in transient focal ischemia. Brain Res. 839:1999;283-291.
179. Li P.A., Kristian T., He Q.P., Siesjo B.K. Cyclosporin A enhances survival, ameliorates brain damage, and prevents secondary mitochondrial dysfunction after a 30-minute period of transient cerebral ischemia. Exp. Neurol. 165:2000;153-163.
180. Hoorens A., Pipeleers D. Nicotinamide protects human beta cells against chemically-induced necrosis, but not against cytokine-induced apoptosis. Diabetologia. 42:1999;55-59.
181. Mabley J.G., Suarez-Pinzon W.L., Hasko G., Salzman A.L., Rabinovitch A., Kun E., Szabo C. Inhibition of poly (ADP-ribose) synthetase by gene disruption or inhibition with 5-iodo-6-amino-1,2-benzopyrone protects mice from multiple-low-dose-streptozotocin-induced diabetes. Br. J. Pharmacol. 133:2001;909-919.
182. Liu D., Pavlovic D., Chen M.C., Flodstrom M., Sandler S., Eizirik D.L. Cytokines induce apoptosis in beta-cells isolated from mice lacking the inducible isoform of nitric oxide synthase (iNOS-/-). Diabetes. 49:2000;1116-1122.
183. Wirtz-Brugger F., Giovanni A. Guanosine 3′,5′-cyclic monophosphate mediated inhibition of cell death induced by nerve growth factor withdrawal and beta-amyloid protective effects of propentofylline . Neuroscience. 99:2000;737-750.
184. Schimming R., Mason K.A., Hunter N., Weil M., Kishi K., Milas L. Lack of correlation between mitotic arrest or apoptosis and antitumor effect of docetaxel. Cancer Chemother. Pharmacol. 43:1999;165-172.
185. Tannock I.F., Lee C. Evidence against apoptosis as a major mechanism for reproductive cell death following treatment of cell lines with anti-cancer drugs. Br. J. Cancer. 84:2001;100-105.
186. Vile R.G., Castleden S., Marshall J., Camplejohn R., Upton C., Chong H. Generation of an anti-tumour immune response in a non-immunogenic tumour HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1-like profile of intratumoural cytokine expression . Int. J. Cancer. 71:1997;267-274.
187. Savill J., Fadok V., Henson P., Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunol. Today. 14:1993;131-136.
188. Olive P.L., Vikse C.M., Vanderbyl S. Increase in the fraction of necrotic, not apoptotic, cells in SiHa xenograft tumours shortly after irradiation. Radiother. Oncol. 50:1999;113-119.
189. Dahle J., Bagdonas S., Kaalhus O., Olsen G., Steen H.B., Moan J. The bystander effect in photodynamic inactivation of cells. Biochim. Biophys. Acta. 1475:2000;273-280.
190. Lavie G., Kaplinsky C., Toren A., Aizman I., Meruelo D., Mazur Y., Mandel M. A photodynamic pathway to apoptosis and necrosis induced by dimethyl tetrahydroxyhelianthrone and hypericin in leukaemic cells possible relevance to photodynamic therapy . Br. J. Cancer. 79:1999;423-432.
191. Demoy M., Minko T., Kopeckova P., Kopecek J. Time- and concentration-dependent apoptosis and necrosis induced by free and HPMA copolymer-bound doxorubicin in human ovarian carcinoma cells. J. Control Release. 69:2000;185-196.
192. Maurer B.J., Metelitsa L.S., Seeger R.C., Cabot M.C., Reynolds C.P. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4- hydroxyphenyl)-retinamide in neuroblastoma cell lines. J. Natl. Cancer Inst. 91:1999;1138-1146.
193. Guillouf C., Wang T.S., Liu J., Walsh C.E., Poirier G.G., Moustacchi E., Rosselli F. Fanconi anemia C protein acts at a switch between apoptosis and necrosis in mitomycin C-induced cell death. Exp. Cell Res. 246:1999;384-394.
194. Borthwick N.J., Wickremasinghe R.G., Lewin J., Fairbanks L.D., Bofill M. Activation-associated necrosis in human immunodeficiency virus infection. J. Infect. Dis. 179:1999;352-360.
195. Plymale D.R., Tang D.S., Comardelle A.M., Fermin C.D., Lewis D.E., Garry R.F. Both necrosis and apoptosis contribute to HIV-1-induced killing of CD4 cells. AIDS. 13:1999;1827-1839.
196. Francois M., Le Cabec V., Dupont M.A., Sansonetti P.J., Maridonneau-Parini I. Induction of necrosis in human neutrophils by Shigella flexneri requires type III secretion, IpaB and IpaC invasins, and actin polymerization. Infect. Immun. 68:2000;1289-1296.
197. Boise L.H., Collins C.M. Salmonella-induced cell death apoptosis, necrosis or programmed cell death? Trends Microbiol. 9:2001;64-67.
198. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., VanMuiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol. Aging. 21:2000;383-421.
199. Ferrer I. Nuclear DNA fragmentation in Creutzfeldt-Jakob disease does a mere positive in situ nuclear end-labeling indicate apoptosis? Acta Neuropathol. (Berlin). 97:1999;5-12.
200. Fujikawa D.G. Confusion between neuronal apoptosis and activation of programmed cell death mechanisms in acute necrotic insults. Trends Neurosci. 23:2000;410-411.
201. Wang J.H., Redmond H.P., Watson R.W., Duggan S., McCarthy J., Barry M., Bouchier-Hayes D. Mechanisms involved in the induction of human endothelial cell necrosis. Cell. Immunol. 168:1996;91-99.
202. Kaplowitz N. Mechanisms of liver cell injury. J. Hepatol. 32:2000;39-47.